Health Care Workers' Perceptions of a Pharmacist-Led Collaborative Practice Agreement for Prescribing Nirmatrelvir/Ritonavir to Eligible Patients with COVID-19
- PMID: 39944758
- PMCID: PMC11801458
- DOI: 10.4212/cjhp.3596
Health Care Workers' Perceptions of a Pharmacist-Led Collaborative Practice Agreement for Prescribing Nirmatrelvir/Ritonavir to Eligible Patients with COVID-19
Conflict of interest statement
Competing interests: For activities unrelated to the study reported here, Douglas Doucette has received reimbursement for travel expenses from the Canadian Society of Hospital Pharmacists (now the Canadian Society of Healthcare-Systems Pharmacy) and has served, since 2011, on the Society’s Hospital Pharmacy in Canada Survey Board. No other competing interests were declared.
Figures


References
-
- Adams BB, Sansom B, Doiron N, Doucette D, Gagnon J, Landry D, et al. The New Brunswick Pharmacy Assessment Clinic: a novel, pharmacist-led, virtual collaborative practice hub for the assessment and prescribing of nirmatrelvir/ritonavir for patients with COVID-19. Can J Hosp Pharm. 2023;76(4):327–30. doi: 10.4212/cjhp.3365. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources